Option Millionaires

[silencedogood2011]

AUXL on major alert.

Biotech Company Auxilium looks to be dealing with major issues that could be a dealt a knockout blow (short to medium term) to the company. Please see below.

Yesterday AUXL lossed a patent battle with Upsher- Smith labs on property rights.

http://ir.auxilium.com/phoenix.zhtml?c=142125&p=irol-newsArticle&ID=1882098&highlight=

The knock out blow could come as early as friday if the FDA does not approve Xiaflex that suppose to help treat Peyronies disease. Xiaflex is already on the market to treat Dupuytren's.


Aegis capital is pro AUXL with a buy rating upped to 33 from 31.

http://www.streetinsider.com/Analyst+Comments/Aegis+Capital+Boosts+PT+on+Auxilium+%28AUXL%29+to+%2433%3B+Xiaflex+Bear+Case+Just+Doesnt+Play+Out/8921817.html

Morgan Stanley and Brean Capital on the other hands do not expect it to be approved.

http://seekingalpha.com/article/1871521-auxilium-serious-red-flags-make-the-upcoming-fda-decision-for-xiaflex-a-high-risk